Similar articles

• [Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease].

  Peleg L, Gazit E, Goldman B, Akstein E. Peleg L, et al. Harefuah. 1995 Dec 1;129(11):475-80. Harefuah. 1995. PMID: 8846957 Review. Hebrew. No abstract available.
• Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.

  Broide E, Zeigler M, Eckstein J, Bach G. Broide E, et al. Am J Med Genet. 1993 Aug 15;47(2):213-5. doi: 10.1002/ajmg.1320470214. Am J Med Genet. 1993. PMID: 8213907
• The rabbi's dilemma. [Interview by Alison George].

  Ekstein J. Ekstein J. New Sci. 2004 Feb 14-20;181(2434):44-7. New Sci. 2004. PMID: 15085821 No abstract available.
• Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?

  Zlotogora J, Leventhal A. Zlotogora J, et al. Isr Med Assoc J. 2000 Sep;2(9):665-7. Isr Med Assoc J. 2000. PMID: 11062764
• Tay-Sachs disease carrier screening: a model for prevention of genetic disease.

  Kaplan F. Kaplan F. Genet Test. 1998;2(4):271-92. doi: 10.1089/gte.1998.2.271. Genet Test. 1998. PMID: 10464605 Review.